- Report
- November 2026
- 348 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- October 2024
- 100 Pages
Global
From €5596EUR$5,950USD£4,668GBP
- Report
- December 2023
- 116 Pages
Global
From €4232EUR$4,500USD£3,531GBP
- Report
- April 2025
- 200 Pages
Global
From €7477EUR$7,950USD£6,237GBP
Viberzi is a prescription medication used to treat irritable bowel syndrome with diarrhea (IBS-D) in adults. It is a type of gastrointestinal drug, which is a class of medications used to treat digestive disorders. Viberzi works by blocking certain receptors in the gut that cause pain and diarrhea. It is taken orally, usually once a day.
Viberzi is a relatively new drug, having been approved by the U.S. Food and Drug Administration (FDA) in 2015. It is manufactured by Allergan, a global pharmaceutical company. Other companies in the gastrointestinal drug market include AbbVie, AstraZeneca, and Takeda Pharmaceuticals. Show Less Read more